✦ LIBER ✦

Human epidermal growth factor receptor 2 (HER2) extracellular domain levels are associated with progression-free survival in patients with HER2-positive metastatic breast cancer receiving lapatinib monotherapy

✍ Scribed by Allan Lipton; Kim Leitzel; Suhail M. Ali; Walter Carney; Greg Platek; Klaudia Steplewski; Ron Westlund; Robert Gagnon; Anne-Marie Martin; Julie Maltzman

Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 573 KB
Volume: 117
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.26101

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Serum epidermal growth factor receptor/H

Serum epidermal growth factor receptor/HER-2 predicts poor survival in patients with metastatic breast cancer

✍ Christopher Souder; Kim Leitzel; Suhail M. Ali; Laurence Demers; Dean B. Evans; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 205 KB 👁 2 views

## Abstract ## BACKGROUND. Epidermal growth factor receptor (EGFR, HER‐1, and __erbB__1) is overexpressed in primary breast cancer and had been identified as a poor prognostic factor. ## METHODS. Pretreatment serum EGFR levels were quantified by using an enzyme‐linked immunoadsorbent assay in a